Akebia Therapeutics, Inc. (AKBA)
0.9001
-0.01
(-0.72%)
USD |
NASDAQ |
Aug 24, 16:00
0.9001
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics Debt to Equity Ratio : 8.426 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.426 |
| March 31, 2026 | 7.961 |
| December 31, 2025 | 6.633 |
| September 30, 2025 | 5.128 |
| June 30, 2025 | 7.205 |
| March 31, 2025 | 8.388 |
| December 31, 2024 | -3.958 |
| September 30, 2024 | -3.792 |
| June 30, 2024 | -3.100 |
| March 31, 2024 | -3.608 |
| December 31, 2023 | -3.406 |
| September 30, 2023 | -2.886 |
| June 30, 2023 | -4.30 |
| March 31, 2023 | -9.750 |
| December 31, 2022 | 30.07 |
| September 30, 2022 | 11.49 |
| June 30, 2022 | 3.067 |
| March 31, 2022 | 7.286 |
| December 31, 2021 | 2.556 |
| September 30, 2021 | 1.271 |
| June 30, 2021 | 0.9925 |
| March 31, 2021 | 0.8048 |
| December 31, 2020 | 0.51 |
| September 30, 2020 | 0.3315 |
| June 30, 2020 | 0.2874 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2709 |
| December 31, 2019 | 0.2744 |
| September 30, 2019 | 0.0721 |
| June 30, 2019 | 0.0671 |
| March 31, 2019 | 0.0635 |
| December 31, 2018 | 0.0236 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.0002 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.0001 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.0001 |
| March 31, 2014 | 0.0001 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Emergent BioSolutions, Inc. | 1.723 |
| Exelixis, Inc. | 0.09 |
| ADMA Biologics, Inc. | 0.4994 |
| Arcutis Biotherapeutics, Inc. | 0.5174 |
| Relay Therapeutics, Inc. | 0.0344 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 349.66M |
| Total Liabilities (Quarterly) | 324.64M |
| Shareholders Equity (Quarterly) | 25.02M |
| Current Ratio | 1.427 |
| Net Debt Paydown Yield | -0.30% |